Plakoglobin (γ-catenin) is a prognostic marker in breast cancer.

被引：0
|
作者：
Buehler, H
Mahnke, E
Duvnjak, B
Schaller, G
机构：
[1] Ruhr Univ Bochum, Marienhosp Herne, Med Ctr, D-4630 Bochum, Germany
[2] Martin Luther Hosp, Berlin, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [1] β-catenin and plakoglobin as prognostic markers in anal cancer.
    Myklebust, Mette Pernille
    Jacob, Havjin
    Dale, Jon Espen
    Dahl, Olav
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Plakoglobin (γ-catenin) mutations in gastric cancer.
    Caca, K
    Kolligs, F
    Hu, G
    Hayes, M
    Fearon, ER
    GASTROENTEROLOGY, 1998, 114 (04) : A573 - A573
  • [3] Osteoprotegerin (OPG) as a prognostic marker in breast cancer.
    Maslyukova, Elizaveta
    Zabroda, Sergey I.
    Koritova, Luiza
    Korytov, Oleg
    Odincov, V.
    Sergeev, Vladimir
    Odincova, Svetlana
    Raskin, Grigoriy
    Vlasova, Ekaterina
    Obuhov, Evgenii
    Bondarenko, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] PTEN: a potential prognostic marker in hormonally treated breast cancer.
    Chagpar, A
    Cheng, HC
    DeCoteau, JF
    Magliocco, A
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 260 - 260
  • [5] Prognostic marker discordance between breast and axilla in patients with early breast cancer.
    Porter, Courtney
    Rockey, Michelle L.
    Grauer, Dennis
    Henry, David W.
    Sharma, Priyanka
    Fan, Fang
    Khan, Qamar J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Plakoglobin is a highly significant prognostic factor in breast cancer
    Mahnke, E.
    Fuchs, I.
    Schaller, G.
    Adamietz, I.
    Buehler, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 20 - 21
  • [7] Loss of CD63 expression as a prognostic marker in breast cancer.
    Shaw, LE
    Seery, LT
    Nicholson, RI
    Darbre, PD
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 296 - 296
  • [8] A novel prognostic marker in ovarian cancer.
    Kyriakopoulou, LG
    Yousef, GM
    Scorilas, A
    Katsaros, D
    Massobrio, M
    Fracchioli, S
    Diamandis, EP
    CLINICAL CHEMISTRY, 2001, 47 (06) : A132 - A132
  • [9] Cell surface GRP78 as a potential prognostic and predictive marker of breast cancer.
    Yerushaimi, Rinat
    Nalpandyan, Karen
    Reiter, Annat
    Hardy, Britta
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Prognostic factors in inflammatory breast cancer.
    Ruiz, A
    Climent, MA
    Liuch, A
    Muñoz, MA
    Poveda, A
    Soriano, V
    Guillem, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S55 - S55
12345